Table 2.
Protocols for myogenic progenitor derivation from iPSC and in vivo testing.
Origin | Method | Myogenic Cells | Mice | Fiber Contribution | Satellite Cell | Ref. |
---|---|---|---|---|---|---|
miPSC | EB on high serum, culture on Matrigel+ SM/C2.6 Ab+ selection | Myoblast-like SM/C2.6+ |
|
|
Yes | [36] |
hiPSC | EB + general differentiation +MyoD1 mRNA | Myoblast-like MyoD1+ | No | - | - | [45] |
miPSC | Inducible Pax7 expression on EB+ PDGFαR+FLK1− selection | Myoblast-like PDGFaR+FLK1− |
|
|
NA * | [38] |
LGMD2D hiPSC | Inducible lentiviral MyoD1 on iPSC-derived MAB-like | MyoD1 expressing mesangioblast- like |
|
|
NA | [46] |
hiPSC | EB+ITS medium + myogenic medium | Myoblast-like MyoD1+, Pax7+, Myf 5+ |
|
|
Yes | [37] |
hiPSC | Inducible Pax7 expression on EB | Pax7+ myoblast-like |
|
(1) Yes (2) Yes (2) Functional improvement |
Yes | [39] |
DMD **-hiPSC | Mesenchyal-like lineage differentiation +adenoviral MyoD1 expression | Myoblast-like MyoD1+ |
|
Yes | NA | [41] |
hiPSC | EB on Matrigel, GSK3 inh., forskolin, bFGF STEMdiff APEL medium | Myoblast-like MyoD1+, Pax7+, Myf 5+, Gata2+ |
|
Yes | Yes | [44] |
hiPSC | ITS Medium+ GSK3 inh. +bFGF+AChR+ sorting | Myoblast-like Pax3+, Pax7+ | No | - | - | [43] |
hiPSC | Piggyback transposon inducible MyoD1 | Myoblast-like MyoD1+ |
|
Low numbers of positive fibers | NA | [32] |
miPSC dKO | Inducible Pax3 expression on EB +PDGFαR+FLK1− selection +μUTR gene correction | Myoblast-like Pax3+ |
|
|
Yes | [40] |
hiPSC BMD &, SMA, ALS | Free floating spherical culture +FGF2, EGF | Myoblast-like | - | - | - | [42] |
* NA = not assessed; ** Duchenne’s Muscular Dystrophy; & Becker’s Muscular Dystrophy; Ref.: Reference.